ScienceDex / Researcher record
David Burkhart
- Inimmune Corporation (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,515,245 | 1 | #3,592 |
| 2025 | $1,648,211 | 1 | #8,849 |
| 2026 | $1,868,922 | 1 | #11,211 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20251 record
- FY2026 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79365733Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing David Burkhart as a PI. Multi-PI records show the full award amount for context.
- 75N93023C00042-P00004-9999-1N01Contact PIDEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES$1.9Maward amount
Award organization
Organizations that administered FY2026 awards listing David Burkhart as a PI.
FY2026 award administered by Inimmune Corporation (MT).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardInimmune Corporation
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3592
- 2024Entered Top 25% NationallyRanked #3592
- 2026$5M Cumulative Funding